- Home
- CCM vs COEP Comparison
CCM vs COEP Comparison
Compare CCM & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- COEP
- Stock Information
- Founded
- CCM 1997
- COEP 2017
- Country
- CCM China
- COEP United States
- Employees
- CCM N/A
- COEP N/A
- Industry
- CCM Medical/Nursing Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCM Health Care
- COEP Health Care
- Exchange
- CCM Nasdaq
- COEP Nasdaq
- Market Cap
- CCM 33.3M
- COEP 27.4M
- IPO Year
- CCM 2009
- COEP N/A
- Fundamental
- Price
- CCM $5.25
- COEP $9.47
- Analyst Decision
- CCM
- COEP
- Analyst Count
- CCM 0
- COEP 0
- Target Price
- CCM N/A
- COEP N/A
- AVG Volume (30 Days)
- CCM 1.9K
- COEP 38.0K
- Earning Date
- CCM 04-25-2025
- COEP 08-15-2025
- Dividend Yield
- CCM N/A
- COEP N/A
- EPS Growth
- CCM N/A
- COEP N/A
- EPS
- CCM N/A
- COEP N/A
- Revenue
- CCM $52,603,198.00
- COEP $62,874.00
- Revenue This Year
- CCM N/A
- COEP N/A
- Revenue Next Year
- CCM N/A
- COEP N/A
- P/E Ratio
- CCM N/A
- COEP N/A
- Revenue Growth
- CCM N/A
- COEP N/A
- 52 Week Low
- CCM $3.80
- COEP $2.31
- 52 Week High
- CCM $10.50
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- CCM 33.93
- COEP 62.24
- Support Level
- CCM $5.50
- COEP $7.25
- Resistance Level
- CCM $5.68
- COEP $9.90
- Average True Range (ATR)
- CCM 0.18
- COEP 0.63
- MACD
- CCM 0.00
- COEP 0.26
- Stochastic Oscillator
- CCM 21.79
- COEP 85.62
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.